878143-33-0 Usage
General Description
Dalasetron (Mesylate hydrate) is a medication belonging to the class of selective serotonin 5-HT3 receptor antagonists. It is used to prevent nausea and vomiting caused by chemotherapy and postoperative procedures. Dalasetron works by blocking the action of serotonin, a chemical in the brain that can trigger nausea and vomiting. The mesylate hydrate form of dalasetron is a stable hydrate salt of dalasetron with mesylate, a common counter-ion. It is a crystalline solid that is soluble in water, and it is typically administered orally or intravenously. Dalasetron (Mesylate hydrate) is considered safe and effective for the prevention of chemotherapy-induced nausea and vomiting in both adults and children. However, it may cause some side effects such as headache, constipation, and dizziness.
Check Digit Verification of cas no
The CAS Registry Mumber 878143-33-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,8,1,4 and 3 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 878143-33:
(8*8)+(7*7)+(6*8)+(5*1)+(4*4)+(3*3)+(2*3)+(1*3)=200
200 % 10 = 0
So 878143-33-0 is a valid CAS Registry Number.
878143-33-0Relevant articles and documents
Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
-
, (2008/06/13)
The present invention is directed to the use of esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and hexahydro-8-hydroxy-2,6-methano-2H-quinolizines in the manufacture of a medicament for the treatment of anxiety, psychosis, glaucoma and for the stimulation of gastric motility.
